What are the surgical guidelines for managing high‑grade endometrial carcinoma?

High-Grade Endometrial Cancer: Surgical Guidelines

For high-grade endometrial cancer, perform total hysterectomy with bilateral salpingo-oophorectomy plus comprehensive surgical staging including both pelvic and para-aortic lymphadenectomy, with maximal cytoreductive surgery for any visible extrauterine disease. 1

Surgical Approach by Stage

Stage I High-Grade Disease

For stage I high-grade endometrial cancer (Grade 3 endometrioid, serous, clear cell, or carcinosarcoma):

• Total hysterectomy and bilateral salpingo-oophorectomy (mandatory)
• Bilateral pelvic AND para-aortic lymphadenectomy 1
  • The SEPAL study demonstrated significantly improved overall survival with combined pelvic and para-aortic lymphadenectomy versus pelvic lymphadenectomy alone in high-risk patients 1
  • This is critical for accurate staging and directing adjuvant therapy decisions
• Peritoneal washings for cytology
• Thorough inspection and palpation of abdominal organs (liver, diaphragm, omentum, peritoneal surfaces)

Sentinel lymph node mapping is emerging as an alternative but requires ultrastaging of all sentinel nodes and side-specific systematic lymphadenectomy if sentinel nodes are not detected 2

Stage II Disease

Radical hysterectomy with bilateral salpingo-oophorectomy and bilateral pelvic-para-aortic lymphadenectomy 1

• Lymphadenectomy is specifically recommended to guide surgical staging and adjuvant therapy decisions
• Preoperative MRI is valuable to assess cervical stromal involvement and plan surgical approach 3

Stage III-IV Disease

Maximal surgical cytoreduction is indicated for patients with good performance status and resectable tumor 1

• For Stage IVA: Consider anterior/posterior pelvic exenteration if needed for complete resection
• For Stage IVB: Hysterectomy with bilateral salpingo-oophorectomy ± lymphadenectomy, with systemic therapy as primary approach
• Palliative surgery may be considered for distant metastatic disease in patients with good performance status

Minimally Invasive Surgery Considerations

Laparoscopy or robotic surgery is preferred when technically feasible 1, 4

• The GOG LAP2 study demonstrated equivalent disease-free and overall survival compared to laparotomy (5-year OS 84.8% for both approaches) 4
• Benefits include: shorter hospital stay, less pain, lower complication rates, improved quality of life
• However, laparotomy is preferred when:
  • Pelvic or abdominal organ involvement is suspected 3
  • Large uterus or elderly patients make minimally invasive approach technically challenging
  • Adequate lymph node dissection cannot be achieved laparoscopically

Critical caveat: Avoid intraperitoneal morcellation—the uterus should be removed en bloc 4

Key Surgical Staging Requirements

High-grade tumors warrant full surgical staging by gynecologic oncologists because they are at high risk for extrauterine spread 3

The role of preoperative imaging (particularly MRI) is to:

• Identify extrauterine metastases or spread
• Plan surgical approach (minimally invasive vs. laparotomy)
• Assess surrogate markers of lymph node metastases (deep myometrial invasion, cervical stromal involvement) 3

Important Pitfalls to Avoid

1. Do not rely on preoperative grade alone: 15-20% of cases are upgraded on final pathology 5
2. Do not omit para-aortic lymphadenectomy in high-risk disease: The survival benefit is specifically demonstrated in this population 1
3. Do not perform routine systematic lymphadenectomy in low-risk disease: This applies only to Stage I Grade 1-2 with minimal invasion, NOT high-grade tumors 1
4. Do not preserve ovaries in high-grade histologies: Bilateral salpingo-oophorectomy is mandatory 2

Medically Inoperable Patients

For patients with medical contraindications to standard surgery:

• Definitive curative radiotherapy is the treatment of choice
• Combination of external beam radiotherapy plus intrauterine image-guided brachytherapy for high-grade tumors 2
• Vaginal hysterectomy with bilateral salpingo-oophorectomy may be considered if feasible 2

Adjuvant Therapy Integration

The surgical findings directly determine adjuvant therapy:

• Combined chemotherapy and radiotherapy has demonstrated 36% reduction in relapse risk and improved cancer-specific survival (HR 0.55) in high-risk endometrial cancer 1
• Guideline-concordant therapy significantly improves overall survival (HR 0.623) and recurrence-free survival (HR 0.578) in high-grade disease 6